[artículo] 
inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 365-369

Título :	Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine
Tipo de documento:	texto impreso
Autores:	Maurizio Fava, Autor ; Patrick J. McGrath, Autor ; Wang Pui Sheu, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 365-369
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antidepresivos, Trastorno depresivo mayor, Resistencia a los medicamentos, Fluoxetina, Morfolinas.
Resumen:	The aim of the present study was to evaluate the efficacy and safety of an immediate switch to reboxetine, a selective noradrenaline reuptake inhibitor (selective NRI), in patients with depression unresponsive to the selective serotonin reuptake inhibitor (SSRI) fluoxetine.
Link:	./index.php?lvl=notice_display&id=31011

[artículo] Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine [texto impreso] / Maurizio Fava, Autor ; Patrick J. McGrath, Autor ; Wang Pui Sheu, Autor . - 2023 . - pp. 365-369.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 365-369

Palabras clave:	Antidepresivos, Trastorno depresivo mayor, Resistencia a los medicamentos, Fluoxetina, Morfolinas.
Resumen:	The aim of the present study was to evaluate the efficacy and safety of an immediate switch to reboxetine, a selective noradrenaline reuptake inhibitor (selective NRI), in patients with depression unresponsive to the selective serotonin reuptake inhibitor (SSRI) fluoxetine.
Link:	./index.php?lvl=notice_display&id=31011